|
"We play a critical role in managing and moving market share. I think the device sector has not necessarily acknowledged the role of the GPOs, but I think increasingly, as products mature in particular, GPOs play a vital role in helping to drive market share up on behalf of a supplier." — Novation CEO Jody Hatcher Photo gallery: MassDevice.com’s Big 100 Roundtable West MassDevice held its 2nd annual Big 100 Roundtable West event in Newport Beach, Calif., December 11. A group of nearly med-tech executives and stakeholders gathered for an evening of networking, insight into medical device marketing and intimate interviews with David Pyott, CEO of Allergan; Tom Prescott, CEO of Align Technology; James Mazzo, president of Abbott Medical Optics; and Robert Grant, chairman and Strathspey Crown. MassDevice Big 100 Roundtable West 2012 Slideshow page 8
Abbott Medical Optics president James Mazzo with CHI co-founder David Gollaher. MassDevice Big 100 Roundtable West 2012 Slideshow page 7
Align Technology CEO Tom Prescott chats with an event attendee between presentations. MassDevice Big 100 Roundtable West 2012 Slideshow page 6
MassDevice publisher Brian Johnson with Abbott Medical Optics president James Mazzo, Align Technology CEO Tom Prescott and Allergan CEO David Pyott. MassDevice Big 100 Roundtable West 2012 Slideshow page 5
Attendees enjoyed food and drink between presentations. MassDevice Big 100 Roundtable West 2012 Slideshow page 4
From left to right: Align Technology CEO Tom Prescott, panel moderator and California Healthcare Institute co-founder David Gollaher, Strathspey Crown chairman Robert Grant and Abbott Medical Optics president James Mazzo. MassDevice Big 100 Roundtable West 2012 Slideshow page 3
Allergan CEO David Pyott tells MassDevice publisher Brian Johnson how to run a successful aesthetics device business. MassDevice Big 100 Roundtable West 2012 Slideshow page 2
MassDevice publisher Brian Johnson addresses an audience of medical device executives and other industry stakeholders. Strathspey Crown and the first Medicare-Medicaid opt-out company in medtech | A conversation with Robert Grant If Robert Grant is successful – a good bet, judging by his track record – 1 day his new venture, private equity firm Strathspey Crown, will be known as a leader in the nascent field of "lifestyle medicine." 
|
